- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 172.49M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $48.74M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $48.62M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.56B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.32B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $7.23B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $7.42B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.95B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.13B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $8.77B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.93B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $750.54M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $258.25M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 110.48M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $98.88M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $124.62M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.38B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.34B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.38 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.38 |
| Net Income | Q1 2025 · Mar 31, 2024 | $42.6M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $50.89M |